Paris
Paris
The plant known as Paris, also referred to as "lily-of-the-valley," has not been traditionally used for medicinal purposes in any recorded practices. Scientific evidence is limited and primarily focuses on its use in managing equine dental conditions post-extraction rather than human health applications. Studies indicate that there may be a significant misclassification rate of primary biliary cholangitis (PBC) patients, which could impact treatment decisions; however, the evidence base for Paris itself remains inconclusive. There are no known drug interactions or major safety concerns associated with this plant.
- 最佳证据
- D
- 注意事项
- —
仅供参考。传统用法并不代表已被证实有效。证据与安全性各不相同，请查阅所引来源。
科学怎么说
- 临床判断与正式的巴黎II标准之间存在约20%的分类错误，这可能会影响PBC患者的治疗决策。
- 该回顾总结了马颊齿牙槽窝术后管理的当前实践和材料，但未制定标准化协议。
- 研究发现，在巴黎医院使用cefotaxime代替ceftriaxone会增加碳排放、废物产生和成本。
- 患有MARS1相关肺泡蛋白沉积病的儿童表现出边缘到轻度智力障碍和显著适应行为缺陷，尽管有甲硫氨酸补充。
- 医疗保健质量系统的有效性更多地取决于领导层的承诺和员工参与，而不是仅靠正式采纳，对患者结果的直接影响证据参差不齐。
- 在正常呼吸期间进行的SSM测量比屏气测量更能准确地预测食管静脉曲张。
Frequently asked questions
What is Paris?
Paris (Paris) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Paris?
6 sourced findings are recorded for Paris; the strongest carries evidence grade D. For example: 临床判断与正式的巴黎II标准之间存在约20%的分类错误，这可能会影响PBC患者的治疗决策。
How strong is the evidence for Paris?
The strongest finding for Paris carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Paris safe? What are the side effects?
No major safety issues are recorded for Paris in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Paris interact with medications?
No drug interactions are recorded for Paris in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Paris?
Paris is also known as: Вороний глаз, Parisette.
Is Paris a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
来源
- T2 The environmental impacts and costs of cefotaxime versus ceftriaxone: An example drawn from Paris hospitals. literature abstract metadata
- T2 Management of Equine Post-Extraction Cheek Tooth Alveoli: Application of Alveolar Plugs. literature abstract metadata
- T2 Healthcare Quality Systems: International Frameworks, Evaluation and Improvement Strategies. literature abstract metadata
- T2 Misclassification of UDCA treatment response in patients with primary biliary cholangitis (PBC) in the real-world setting. literature abstract metadata
- T2 Neurodevelopmental Profile of Children With MARS1-Related Pulmonary Alveolar Proteinosis: A Cohort Study. literature abstract metadata
- T2 Impact of Breath Holding on Spleen Stiffness Measured by 100 Hz Vibration Controlled Transient Elastography. literature abstract metadata